Global Natural Killer Cell Therapy Market Growth (Status and Outlook) 2025-2031

January 2025 | 92 pages | ID: G123DA3A1E8DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Natural Killer Cell Therapy market size is predicted to grow from US$ 385 million in 2025 to US$ 1475 million in 2031; it is expected to grow at a CAGR of 25.1% from 2025 to 2031.

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

LPI (LP Information)' newest research report, the “Natural Killer Cell Therapy Industry Forecast” looks at past sales and reviews total world Natural Killer Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Natural Killer Cell Therapy sales for 2025 through 2031. With Natural Killer Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Natural Killer Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Natural Killer Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer Cell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• NK Cell Therapies
• NK Cell Directed Antibodies

Segmentation by Application:

• Cancer
• Gastrointestinal Diseases
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Nektar Therapeutics
• Innate Pharma SA
• Affimed
• Chipscreen Biosciences
• Glycostem Therapeutics
• Fate Therapeutics
• Dragonfly Therapeutics
• Kiadis Pharma
• Nkarta Therapeutics
• NantKwest

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Natural Killer Cell Therapy Market Size (2020-2031)
  2.1.2 Natural Killer Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Natural Killer Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 Natural Killer Cell Therapy Segment by Type
  2.2.1 NK Cell Therapies
  2.2.2 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy Market Size by Type
  2.3.1 Natural Killer Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Natural Killer Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 Natural Killer Cell Therapy Segment by Application
  2.4.1 Cancer
  2.4.2 Gastrointestinal Diseases
  2.4.3 Others
2.5 Natural Killer Cell Therapy Market Size by Application
  2.5.1 Natural Killer Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Natural Killer Cell Therapy Market Size Market Share by Application (2020-2025)

3 NATURAL KILLER CELL THERAPY MARKET SIZE BY PLAYER

3.1 Natural Killer Cell Therapy Market Size Market Share by Player
  3.1.1 Global Natural Killer Cell Therapy Revenue by Player (2020-2025)
  3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Natural Killer Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NATURAL KILLER CELL THERAPY BY REGION

4.1 Natural Killer Cell Therapy Market Size by Region (2020-2025)
4.2 Global Natural Killer Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Natural Killer Cell Therapy Market Size Growth (2020-2025)
4.4 APAC Natural Killer Cell Therapy Market Size Growth (2020-2025)
4.5 Europe Natural Killer Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Natural Killer Cell Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Natural Killer Cell Therapy Market Size by Country (2020-2025)
5.2 Americas Natural Killer Cell Therapy Market Size by Type (2020-2025)
5.3 Americas Natural Killer Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Natural Killer Cell Therapy Market Size by Region (2020-2025)
6.2 APAC Natural Killer Cell Therapy Market Size by Type (2020-2025)
6.3 APAC Natural Killer Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Natural Killer Cell Therapy Market Size by Country (2020-2025)
7.2 Europe Natural Killer Cell Therapy Market Size by Type (2020-2025)
7.3 Europe Natural Killer Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Natural Killer Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NATURAL KILLER CELL THERAPY MARKET FORECAST

10.1 Global Natural Killer Cell Therapy Forecast by Region (2026-2031)
  10.1.1 Global Natural Killer Cell Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Natural Killer Cell Therapy Forecast
  10.1.3 APAC Natural Killer Cell Therapy Forecast
  10.1.4 Europe Natural Killer Cell Therapy Forecast
  10.1.5 Middle East & Africa Natural Killer Cell Therapy Forecast
10.2 Americas Natural Killer Cell Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Natural Killer Cell Therapy Forecast
  10.2.2 Canada Market Natural Killer Cell Therapy Forecast
  10.2.3 Mexico Market Natural Killer Cell Therapy Forecast
  10.2.4 Brazil Market Natural Killer Cell Therapy Forecast
10.3 APAC Natural Killer Cell Therapy Forecast by Region (2026-2031)
  10.3.1 China Natural Killer Cell Therapy Market Forecast
  10.3.2 Japan Market Natural Killer Cell Therapy Forecast
  10.3.3 Korea Market Natural Killer Cell Therapy Forecast
  10.3.4 Southeast Asia Market Natural Killer Cell Therapy Forecast
  10.3.5 India Market Natural Killer Cell Therapy Forecast
  10.3.6 Australia Market Natural Killer Cell Therapy Forecast
10.4 Europe Natural Killer Cell Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Natural Killer Cell Therapy Forecast
  10.4.2 France Market Natural Killer Cell Therapy Forecast
  10.4.3 UK Market Natural Killer Cell Therapy Forecast
  10.4.4 Italy Market Natural Killer Cell Therapy Forecast
  10.4.5 Russia Market Natural Killer Cell Therapy Forecast
10.5 Middle East & Africa Natural Killer Cell Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Natural Killer Cell Therapy Forecast
  10.5.2 South Africa Market Natural Killer Cell Therapy Forecast
  10.5.3 Israel Market Natural Killer Cell Therapy Forecast
  10.5.4 Turkey Market Natural Killer Cell Therapy Forecast
10.6 Global Natural Killer Cell Therapy Forecast by Type (2026-2031)
10.7 Global Natural Killer Cell Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Natural Killer Cell Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Nektar Therapeutics
  11.1.1 Nektar Therapeutics Company Information
  11.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Offered
  11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Nektar Therapeutics Main Business Overview
  11.1.5 Nektar Therapeutics Latest Developments
11.2 Innate Pharma SA
  11.2.1 Innate Pharma SA Company Information
  11.2.2 Innate Pharma SA Natural Killer Cell Therapy Product Offered
  11.2.3 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Innate Pharma SA Main Business Overview
  11.2.5 Innate Pharma SA Latest Developments
11.3 Affimed
  11.3.1 Affimed Company Information
  11.3.2 Affimed Natural Killer Cell Therapy Product Offered
  11.3.3 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Affimed Main Business Overview
  11.3.5 Affimed Latest Developments
11.4 Chipscreen Biosciences
  11.4.1 Chipscreen Biosciences Company Information
  11.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Offered
  11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Chipscreen Biosciences Main Business Overview
  11.4.5 Chipscreen Biosciences Latest Developments
11.5 Glycostem Therapeutics
  11.5.1 Glycostem Therapeutics Company Information
  11.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Offered
  11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Glycostem Therapeutics Main Business Overview
  11.5.5 Glycostem Therapeutics Latest Developments
11.6 Fate Therapeutics
  11.6.1 Fate Therapeutics Company Information
  11.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Offered
  11.6.3 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Fate Therapeutics Main Business Overview
  11.6.5 Fate Therapeutics Latest Developments
11.7 Dragonfly Therapeutics
  11.7.1 Dragonfly Therapeutics Company Information
  11.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Offered
  11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Dragonfly Therapeutics Main Business Overview
  11.7.5 Dragonfly Therapeutics Latest Developments
11.8 Kiadis Pharma
  11.8.1 Kiadis Pharma Company Information
  11.8.2 Kiadis Pharma Natural Killer Cell Therapy Product Offered
  11.8.3 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Kiadis Pharma Main Business Overview
  11.8.5 Kiadis Pharma Latest Developments
11.9 Nkarta Therapeutics
  11.9.1 Nkarta Therapeutics Company Information
  11.9.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Offered
  11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Nkarta Therapeutics Main Business Overview
  11.9.5 Nkarta Therapeutics Latest Developments
11.10 NantKwest
  11.10.1 NantKwest Company Information
  11.10.2 NantKwest Natural Killer Cell Therapy Product Offered
  11.10.3 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 NantKwest Main Business Overview
  11.10.5 NantKwest Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Natural Killer CellTherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Natural Killer CellTherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of NK CellTherapies
Table 4. Major Players of NK Cell Directed Antibodies
Table 5. Natural Killer CellTherapy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Natural Killer CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 7. Global Natural Killer CellTherapy Market Size Market Share byType (2020-2025)
Table 8. Natural Killer CellTherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Natural Killer CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Natural Killer CellTherapy Market Size Market Share by Application (2020-2025)
Table 11. Global Natural Killer CellTherapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Natural Killer CellTherapy Revenue Market Share by Player (2020-2025)
Table 13. Natural Killer CellTherapy Key Players Head office and Products Offered
Table 14. Natural Killer CellTherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Natural Killer CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Natural Killer CellTherapy Market Size Market Share by Region (2020-2025)
Table 19. Global Natural Killer CellTherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Natural Killer CellTherapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Natural Killer CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Natural Killer CellTherapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Natural Killer CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Natural Killer CellTherapy Market Size Market Share byType (2020-2025)
Table 25. Americas Natural Killer CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Natural Killer CellTherapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Natural Killer CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Natural Killer CellTherapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Natural Killer CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Natural Killer CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Natural Killer CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Natural Killer CellTherapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Natural Killer CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Natural Killer CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Natural Killer CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Natural Killer CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Natural Killer CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Natural Killer CellTherapy
Table 39. Key Market Challenges & Risks of Natural Killer CellTherapy
Table 40. Key IndustryTrends of Natural Killer CellTherapy
Table 41. Global Natural Killer CellTherapy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Natural Killer CellTherapy Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Natural Killer CellTherapy Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Natural Killer CellTherapy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. NektarTherapeutics Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 46. NektarTherapeutics Natural Killer CellTherapy Product Offered
Table 47. NektarTherapeutics Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. NektarTherapeutics Main Business
Table 49. NektarTherapeutics Latest Developments
Table 50. Innate Pharma SA Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 51. Innate Pharma SA Natural Killer CellTherapy Product Offered
Table 52. Innate Pharma SA Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Innate Pharma SA Main Business
Table 54. Innate Pharma SA Latest Developments
Table 55. Affimed Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 56. Affimed Natural Killer CellTherapy Product Offered
Table 57. Affimed Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Affimed Main Business
Table 59. Affimed Latest Developments
Table 60. Chipscreen Biosciences Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 61. Chipscreen Biosciences Natural Killer CellTherapy Product Offered
Table 62. Chipscreen Biosciences Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Chipscreen Biosciences Main Business
Table 64. Chipscreen Biosciences Latest Developments
Table 65. GlycostemTherapeutics Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 66. GlycostemTherapeutics Natural Killer CellTherapy Product Offered
Table 67. GlycostemTherapeutics Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. GlycostemTherapeutics Main Business
Table 69. GlycostemTherapeutics Latest Developments
Table 70.FateTherapeutics Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 71.FateTherapeutics Natural Killer CellTherapy Product Offered
Table 72.FateTherapeutics Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.FateTherapeutics Main Business
Table 74.FateTherapeutics Latest Developments
Table 75. DragonflyTherapeutics Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 76. DragonflyTherapeutics Natural Killer CellTherapy Product Offered
Table 77. DragonflyTherapeutics Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. DragonflyTherapeutics Main Business
Table 79. DragonflyTherapeutics Latest Developments
Table 80. Kiadis Pharma Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 81. Kiadis Pharma Natural Killer CellTherapy Product Offered
Table 82. Kiadis Pharma Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Kiadis Pharma Main Business
Table 84. Kiadis Pharma Latest Developments
Table 85. NkartaTherapeutics Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 86. NkartaTherapeutics Natural Killer CellTherapy Product Offered
Table 87. NkartaTherapeutics Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. NkartaTherapeutics Main Business
Table 89. NkartaTherapeutics Latest Developments
Table 90. NantKwest Details, CompanyType, Natural Killer CellTherapy Area Served and Its Competitors
Table 91. NantKwest Natural Killer CellTherapy Product Offered
Table 92. NantKwest Natural Killer CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. NantKwest Main Business
Table 94. NantKwest Latest Developments



LIST OFFIGURES

Figure 1. Natural Killer CellTherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer CellTherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Natural Killer CellTherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Natural Killer CellTherapy Sales Market Share by Country/Region (2024)
Figure 8. Natural Killer CellTherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Natural Killer CellTherapy Market Size Market Share byType in 2024
Figure 10. Natural Killer CellTherapy in Cancer
Figure 11. Global Natural Killer CellTherapy Market: Cancer (2020-2025) & ($ millions)
Figure 12. Natural Killer CellTherapy in Gastrointestinal Diseases
Figure 13. Global Natural Killer CellTherapy Market: Gastrointestinal Diseases (2020-2025) & ($ millions)
Figure 14. Natural Killer CellTherapy in Others
Figure 15. Global Natural Killer CellTherapy Market: Others (2020-2025) & ($ millions)
Figure 16. Global Natural Killer CellTherapy Market Size Market Share by Application in 2024
Figure 17. Global Natural Killer CellTherapy Revenue Market Share by Player in 2024
Figure 18. Global Natural Killer CellTherapy Market Size Market Share by Region (2020-2025)
Figure 19. Americas Natural Killer CellTherapy Market Size 2020-2025 ($ millions)
Figure 20. APAC Natural Killer CellTherapy Market Size 2020-2025 ($ millions)
Figure 21. Europe Natural Killer CellTherapy Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Natural Killer CellTherapy Market Size 2020-2025 ($ millions)
Figure 23. Americas Natural Killer CellTherapy Value Market Share by Country in 2024
Figure 24. United States Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Natural Killer CellTherapy Market Size Market Share by Region in 2024
Figure 29. APAC Natural Killer CellTherapy Market Size Market Share byType (2020-2025)
Figure 30. APAC Natural Killer CellTherapy Market Size Market Share by Application (2020-2025)
Figure 31. China Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. India Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Natural Killer CellTherapy Market Size Market Share by Country in 2024
Figure 38. Europe Natural Killer CellTherapy Market Size Market Share byType (2020-2025)
Figure 39. Europe Natural Killer CellTherapy Market Size Market Share by Application (2020-2025)
Figure 40. Germany Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 41.France Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Natural Killer CellTherapy Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Natural Killer CellTherapy Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Natural Killer CellTherapy Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Natural Killer CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 54. APAC Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 55. Europe Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 57. United States Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 58. Canada Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 59. Mexico Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 60. Brazil Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 61. China Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 62. Japan Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 63. Korea Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 65. India Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 66. Australia Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 67. Germany Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 68.France Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 69. UK Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 70. Italy Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 71. Russia Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 72. Egypt Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 73. South Africa Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 74. Israel Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 75.Turkey Natural Killer CellTherapy Market Size 2026-2031 ($ millions)
Figure 76. Global Natural Killer CellTherapy Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Natural Killer CellTherapy Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Natural Killer CellTherapy Market Size 2026-2031 ($ millions)